ESMO 2022 Conference Coverage
ESMO 2022 on Doxorubicin Eluting Embolotherapy for Desmoid Fibromatosis
By
ESMO 2022 Conference Coverage
FEATURING
Eldad Elnekave
By
ESMO 2022 Conference Coverage
FEATURING
Eldad Elnekave
Login to view comments.
Click here to Login
